ketoconazole

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instanceOf antiviral drug
imidazole derivative
gptkbp:approvedBy 1981
gptkbp:ATCCode gptkb:D01AC08
gptkbp:brand gptkb:Nizoral
gptkb:Extina
gptkb:Xolegel
gptkbp:CASNumber gptkb:65277-42-1
gptkbp:contraindication gptkb:liver_disease
hypersensitivity to ketoconazole
gptkbp:discoveredBy gptkb:Janssen_Pharmaceutica
gptkbp:drugInteraction gptkb:proton_pump_inhibitors
gptkb:phenytoin
gptkb:rifampin
statins
anticoagulants
antacids
gptkbp:eliminationHalfLife 2 hours
gptkbp:excretion urine
bile
gptkbp:hasMolecularFormula gptkb:C26H28Cl2N4O4
https://www.w3.org/2000/01/rdf-schema#label ketoconazole
gptkbp:IUPACName gptkb:cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine
gptkbp:KEGGID gptkb:D00351
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits ergosterol synthesis
inhibits fungal cytochrome P450
gptkbp:MeSH_ID gptkb:D007668
gptkbp:metabolism liver
gptkbp:molecularWeight 531.43 g/mol
gptkbp:pregnancyCategory C (US)
gptkbp:PubChem_CID 3691
3823
CHEMBL685
gptkbp:regulates oral formulation withdrawn in several countries due to hepatotoxicity
gptkbp:riskFactor QT prolongation
adrenal suppression
drug-induced hepatitis
gptkbp:routeOfAdministration oral
topical
gptkbp:sideEffect nausea
vomiting
abdominal pain
pruritus
hepatotoxicity
gynecomastia
adrenal insufficiency
gptkbp:UNII R9400W9272
gptkbp:usedFor treatment of fungal infections
treatment of dandruff
treatment of seborrheic dermatitis
treatment of tinea versicolor
gptkbp:WHOModelListOfEssentialMedicines yes
gptkbp:bfsParent gptkb:CYP3_family
gptkb:CYP3A4
gptkb:Emend
gptkb:Imodium
gptkbp:bfsLayer 5